艾伯维Abbvie Inc （ABBV） 2018年负责任行动报告「NYSE」.pdf

1、2018ResponsibleAction Report 2018 Responsible Action Report 3A message from our CEOAt AbbVie,we are guided in everything we do by our desire to make a remarkable impact on the lives of patients.We strive to do this by discovering and developing a consistent stream of innovative medicines that make a

2、 real difference for people facing serious health problems.We have convened a world-class research organization and a diverse,talented and engaged workforce.Together they have developed important medicines that are benefitting patients with autoimmune conditions,cancer,hepatitis C,Parkinsons disease

3、,endometriosis and other complex diseases.As we look forward,we want to continue to be a long-term partner in the pursuit of better health outcomes.We know that doing so means thinking broadly about how we can use our expertise to advance health and wellness.It means building and maintaining the tru

4、st of all who rely on us,protecting our environment and understanding how we can be helpful members of the local and global community.Our company,our employees and our partners have done much in 2018 to advance those priorities.I am proud of our scientific advancements,public health engagement,commi

5、tment to diversity and talent development and the historic contribution of$350 million to U.S.nonprofit organizations supporting long-term community strength.It is my pleasure to introduce the AbbVie 2018 Responsible Action Report.It reflects ways in which weve worked to positively impact the lives

6、of our patients,employees,partners and communities around the world.Sincerely,Rick Gonzalez Chairman&CEO“We are guided in everything we do by our desire to makea remarkable impact on the lives of patients.”Table of contents A message from our CEO 3Who we are 42018 highlights 5Our corporate responsib